Effect of low level laser therapy on bronchial hyper-responsiveness

被引:7
|
作者
Aimbire, Flavio [1 ,2 ]
de Lima, Flavia Mafra [2 ]
Costa, Maricilia S. [2 ]
Albertini, Regiane [2 ]
Correa, Joo Carlos [2 ]
Iversen, Vegard V. [3 ]
Bjordal, Jan M. [4 ]
机构
[1] Univ Vale Paraiba, Inst Pesquisa & Desenvolvimento, Anim Expt Lab, BR-12244000 Sao Jose Dos Campos, SP, Brazil
[2] Univ Vale Paraiba, Inst Res & Dev, BR-12244000 Sao Jose Dos Campos, SP, Brazil
[3] Bergen Univ Coll, Inst Physiotherapy, Bergen, Norway
[4] Univ Bergen, Dept Biomed, Physiol Sect, Bergen, Norway
关键词
Bronchial hyper-responsiveness; Ca2+ sensitization; Inositol phosphate; Low level laser therapy; Rat; TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; MEDIATED CA2+ SENSITIZATION; FACTOR-ALPHA; TNF-ALPHA; RECEPTOR SUBTYPES; MUSCARINIC REGULATION; RYANODINE RECEPTORS; FREE CALCIUM; AIRWAY;
D O I
10.1007/s10103-008-0612-9
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The objective of this study was to investigate whether low level laser therapy (LLLT) could reduce bronchial hyper-responsiveness (BHR) induced by tumour necrosis factor-alpha (TNF-alpha) modulating the metabolism of inositol phosphate (IP) in bronchial smooth muscle cells (BSMCs). The study was on 28 Wistar rats, randomly divided into four groups. Irradiation (1.3 J/cm(2)) was administered 5 min and 4 h after bronchial smooth muscle (BSM) had been suspended in TNF-alpha baths, and the contractile response-induced calcium ion (Ca2+) sensitization was measured. The BSMCs were isolated, and the IP accumulation was measured before and after TNF-alpha immersion in the groups that had been irradiated or not irradiated. BSM segments significantly increased contraction 24 h after TNF-alpha immersion when exposed to carbachol (CCh) as Ca2+, but it was significantly reduced by 64% and 30%, respectively, after laser treatment. The increase in IP accumulation induced by CCh after TNF-alpha immersion was reduced in the BSMCs by LLLT. The dose of 2.6 J/cm(2) reduced BHR and IP accumulation in the rats' inflammatory BSMCs.
引用
收藏
页码:567 / 576
页数:10
相关论文
共 50 条
  • [31] Small Airways Dysfunction and Bronchial Hyper-Responsiveness in Cough Variant Asthma
    Gao, Jie
    Wu, Hai Gui
    Wu, Feng
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2020, 13 : 1427 - 1434
  • [32] Testing bronchial hyper-responsiveness: Provocation or peak expiratory flow variability?
    denOtter, JJ
    Reijnen, GMW
    VandenBosch, WJHM
    VanSchayck, CP
    Molema, J
    VanWeel, C
    BRITISH JOURNAL OF GENERAL PRACTICE, 1997, 47 (421): : 487 - 492
  • [33] Allergen sensitization and bronchial hyper-responsiveness to adenosine monophosphate in asthmatic patients
    Currie, GP
    Jackson, CM
    Lee, DKC
    Lipworth, BJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 2003, 33 (10): : 1405 - 1408
  • [34] VO2 kinetics and bronchial hyper-responsiveness in professional cyclists
    Medelli, J.
    Marefati, H.
    Campion, F.
    Lounana, J.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 95 - 95
  • [35] Prevalence of bronchial hyper-responsiveness in the southern, central and northern parts of Sweden
    Norrman, E
    Plaschke, P
    Bjornsson, E
    Rosenhall, L
    Lundback, B
    Jansson, C
    Lindholm, N
    Boman, G
    RESPIRATORY MEDICINE, 1998, 92 (03) : 480 - 487
  • [36] A detailed genetic map of the chromosome 7 bronchial hyper-responsiveness locus
    Nicholas I Leaves
    Sumit Bhattacharyya
    Steven Wiltshire
    William OCM Cookson
    European Journal of Human Genetics, 2002, 10 : 177 - 182
  • [37] Eosinophil peroxidase: A new serum marker of atopy and bronchial hyper-responsiveness
    Bjornsson, E
    Janson, C
    Hakansson, L
    Enander, I
    Venge, P
    Boman, G
    RESPIRATORY MEDICINE, 1996, 90 (01) : 39 - 46
  • [38] Effect of Mycobacterium tuberculosis chaperonins on bronchial eosinophilia and hyper-responsiveness in a murine model of allergic inflammation
    Riffo-Vasquez, Y
    Spina, D
    Page, C
    Tormay, P
    Singh, M
    Henderson, B
    Coates, A
    CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (05): : 712 - 719
  • [39] Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma
    Myou, S
    Fujimura, M
    Kamio, Y
    Kita, T
    Watanabe, K
    Ishiura, Y
    Hashimoto, T
    Nakao, S
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (06) : 622 - 626
  • [40] Vasomotor hyper-responsiveness in SCD
    Brousse, Valentine
    Connes, Philippe
    BLOOD, 2020, 136 (10) : 1120 - 1121